On December 26, Johnson & Johnson (NYSE:JNJ) said it ended a mid-stage study of an experimental drug for patients with ...

As a result, finding a compatible dermatologist and solution to eczema is not just logistically difficult but often ...

Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...

According to the National Center for Health and Statistics, under the Centers for Disease Control and Prevention (CDC), ...

Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study ...

Adults with atopic eczema are significantly more likely to experience suicidal thoughts than those without the skin condition ...

Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...

An NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled.

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new ...

A stunningly wide array of factors can trigger eczema symptoms, including those of atopic dermatitis, its most common form, including weather and hormonal changes, environmental allergens, irritants ...